FDA Clearance Tracker · P190023-S001
Portico Heart Valve, FlexNav Delivery System, FlexNav Loading System
Last checked: Nov 20, 2026Latest source record: Nov 12, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Nov 12, 2021
Approved
Time to decision
28 days
Received Oct 15, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P190023-S001
- Device name
- Portico Heart Valve, FlexNav Delivery System, FlexNav Loading System
- Applicant
- ABBOTT MEDICAL
- Applicant location
- St. Paul, MN
- Received
- Oct 15, 2021
- Decided
- Nov 12, 2021
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P190023
Device type
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval of the protocol for the Post Approval Study "Registry-Based Real World Use Surveillance of the Portico TAVI System."
Source documents
Other decisions for ABBOTT MEDICAL
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P260019 · Decided Oct 27, 2026 · 180 days after receipt
Device type: Para-device leak occluder (SJT) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.